发明名称 Lægemidler
摘要 A pharmaceutical formulation comprising (i) one or more particulate medicaments, and (ii) 1,1,1,2-tetrafluoroethane as propellant, which formulation contains less than 0.0001% w/w surfactant based upon the weight of medicament, particulate medicament being present in an amount from 0.005 to 5% w/w relative to the total weight of the formulation and having a particle size of less than 100 microns, with the proviso that said medicament is other than salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate or a physiologically acceptable salt or solvate thereof and with the proviso that when said formulation consists of betamethasone, ergotamine tartrate or sodium cromoglycate and 1,1,1,2-tetrafluoroethane the weight to weight ratio of medicament to propellant is other than 69:7900 or 0.866% w/w.
申请公布号 DK0616524(T3) 申请公布日期 1999.06.21
申请号 DK19920924668T 申请日期 1992.12.04
申请人 GLAXO GROUP LIMITED 发明人 AKEHURST, RACHEL ANN;TAYLOR, ANTHONY JAMES;WYATT, DAVID ANDREW;AKEHURST, RACHEL ANN;TAYLOR, ANTHONY JAMES;WYATT, DAVID ANDREW
分类号 A61K9/127;A61K9/00;A61K9/12;A61K9/14;A61K9/72;A61K31/02;A61K31/135;A61K31/137;A61K31/138;A61K31/167;A61K31/352;A61K31/44;A61K31/4402;A61K31/4458;A61K31/4535;A61K31/46;A61K31/4741;A61K31/48;A61K31/522;A61K31/56;A61K31/57;A61K31/573;A61K45/06;A61L9/04;A61M11/00;A61M15/00;A61P11/00;A61P11/06;A61P11/08;(IPC1-7):A61K9/00 主分类号 A61K9/127
代理机构 代理人
主权项
地址